What is Ayogo?
Founded in 2008, Ayogo has developed the Glimpse Platform, a sophisticated solution designed to enhance patient engagement and adherence to therapeutic regimens. The platform achieves this by personalizing content, tools, and support based on an individual's unique psychosocial characteristics. This tailored approach aims to substantially increase activation, adherence, and persistence to therapy, addressing a critical need in patient care and chronic disease management.
How much funding has Ayogo raised?
Ayogo has raised a total of $10M across 2 funding rounds:
Series A
$2.5M
Series B
$7.5M
Series A (2015): $2.5M with participation from 7Wire Ventures, Excel Venture Management, and Merck Global Health Innovations
Series B (2020): $7.5M led by MEDTEQ, Merck Global Health Innovation Fund, 7Wire Ventures, Baxter International Inc, and Excel Venture Management
Key Investors in Ayogo
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund is a venture capital firm focused on investing in companies that advance healthcare through technology and innovation.
Excel Venture Management
Excel Venture Management is a venture capital firm that invests in early-stage companies, particularly those in the healthcare and technology sectors.
MEDTEQ
MEDTEQ is an organization that supports the development and commercialization of medical technologies, likely investing in innovative healthcare solutions.
What's next for Ayogo?
With the recent major strategic investment, Ayogo is poised for accelerated growth and market penetration. The enterprise-level funding suggests a mature stage of development, likely enabling the company to scale its operations, expand its research and development efforts, and potentially explore new therapeutic areas or geographical markets. This backing will be instrumental in solidifying Ayogo's position as a leader in personalized digital health solutions.
See full Ayogo company page
